5,6-Dihydrodicyclopentadiene

Catalog No.: 
ACDZXF294
CAS No.: 
4488-57-7
Molecular Formula: 
C10H14
Molecular Weight: 
134.22
5,6-Dihydrodicyclopentadiene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%
5g95%
25g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,6-Dihydrodicyclopentadiene
IUPAC Name(4S,7R)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoindene
MDL No.MFCD00213523
Molecular FormulaC10H14
Molecular Weight134.22
SMILES[H][C@@]12CC[C@@](C1)(C3C=CCC23)[H]
InChI KeyHANKSFAYJLDDKP-AFWXGSBKSA-N
Synonym5,6-Dihydrodicyclopentadiene | D2001 | DHDCPD | Tricyclo(5.2.1.0(2,6))dec-4-ene | Tricyclo[5.2.1.02,6]decan-3-ene | 3a,4,7,7a-Tetrahydro-4,7-methanoindan | AKOS025295338 | EINECS 224-778-8 | tricyclo[5.2.1.02,6]dec-3-ene | Laninamivir octanoic acid ester
CAS No.4488-57-7
PubChem CID95605

Safety Data

Pictogram
Flammable
Signal Word
Danger
Hazard Statement(s)
H228-H303
Precautionary Statement(s)
P210-P233-P240-P241+P242+P243-P280-P303+P361+P353-P312-P370+P378-P403+P235-P501

Synthetic Route by SureRoute

1. ACDZXF294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDZXF294 route product structure diagram
    ACDZXF2944488-57-7In Stock
Inquiry

2. ACDZXF294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDZXF294 route product structure diagram
    ACDZXF2944488-57-7In Stock
Inquiry

3. ACDZXF294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDCFR956 route compound structure diagram
    --
  2. Plus
  3. ACDCFR956 route compound structure diagram
    --
  4. Then
  5. ACDZXF294 route product structure diagram
    ACDZXF2944488-57-7In Stock
Inquiry

Comments (0)